Cargando…

The endothelial function biomarker soluble E‐selectin is associated with nonalcoholic fatty liver disease

BACKGROUND & AIMS: Plasma soluble E‐selectin (sE‐selectin) is a frequently used biomarker of systemic endothelial dysfunction. The present study explored the relationship between nonalcoholic fatty liver disease (NAFLD) and plasma sE‐selectin levels. METHODS: Expression of E‐selectin in liver, v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simons, Nynke, Bijnen, Mitchell, Wouters, Kristiaan A. M., Rensen, Sander S., Beulens, Joline W. J., van Greevenbroek, Marleen M. J., ’t Hart, Leen M., Greve, Jan Willem M., van der Kallen, Carla J. H., Schaper, Nicolaas C., Schalkwijk, Casper G., Stehouwer, Coen D. A., Brouwers, Martijn C. G. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Metabolic & Toxic Liver Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317803/ https://www.ncbi.nlm.nih.gov/pubmed/31960587 http://dx.doi.org/10.1111/liv.14384

Ejemplares similares

Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study
por: Bijnen, Mitchell, et al.
Publicado: (2019)

Association of common gene variants in glucokinase regulatory protein with cardiorenal disease: A systematic review and meta-analysis
por: Simons, Pomme I. H. G., et al.
Publicado: (2018)

Inhibition of polyploidization in Pten‐deficient livers reduces steatosis
por: Moreno, Eva, et al.
Publicado: (2022)

Endoplasmic reticulum stress-induced apoptosis in the development of diabetes: is there a role for adipose tissue and liver?
por: van der Kallen, Carla J. H., et al.
Publicado: (2009)

Relationship Between Nonalcoholic Fatty Liver Disease Susceptibility Genes and Coronary Artery Disease
por: Brouwers, Martijn C.G.J., et al.
Publicado: (2019)

Diagnostic accuracy of fibrosis tests in children with non‐alcoholic fatty liver disease: A systematic review
por: Draijer, Laura G., et al.
Publicado: (2021)

Oxidative stress is associated with suspected non‐alcoholic fatty liver disease and all‐cause mortality in the general population
por: Damba, Turtushikh, et al.
Publicado: (2020)

Circulating trimethylamine‐N‐oxide is associated with all‐cause mortality in subjects with nonalcoholic fatty liver disease
por: Flores‐Guerrero, Jose L., et al.
Publicado: (2021)

Glycogenosis is common in nonalcoholic fatty liver disease and is independently associated with ballooning, but lower steatosis and lower fibrosis
por: Allende, Daniela S, et al.
Publicado: (2021)

Incidence of type 2 diabetes in familial combined hyperlipidemia
por: Brouwers, Martijn C G J, et al.
Publicado: (2020)

NAFLD is related to Post‐prandial Triglyceride‐enrichment of HDL Particles in Association with Endothelial and HDL Dysfunction
por: Verwer, Bart J., et al.
Publicado: (2020)

A new framework for advancing in drug‐induced liver injury research. The Prospective European DILI Registry
por: Björnsson, Einar S., et al.
Publicado: (2022)

Dysfunctional adipose tissue and low-grade inflammation in the management of the metabolic syndrome: current practices and future advances
por: van Greevenbroek, Marleen M. J., et al.
Publicado: (2016)

Impact of a Mediterranean diet on hepatic and metabolic outcomes in non‐alcoholic fatty liver disease: The MEDINA randomised controlled trial
por: George, Elena S., et al.
Publicado: (2022)

Complement C3 and C4, but not their regulators or activated products, are associated with incident metabolic syndrome: the CODAM study
por: Xin, Ying, et al.
Publicado: (2018)

Associations of dicarbonyl stress with complement activation: the CODAM study
por: Xin, Ying, et al.
Publicado: (2020)

Impact of osteopontin on the development of non‐alcoholic liver disease and related hepatocellular carcinoma
por: Nardo, Alexander D., et al.
Publicado: (2020)

Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology
por: Calleja, José L., et al.
Publicado: (2022)

Circulating classical monocytes are associated with CD11c(+) macrophages in human visceral adipose tissue
por: Wouters, Kristiaan, et al.
Publicado: (2017)

Polymorphisms in Glyoxalase I Gene Are Not Associated with Glyoxalase I Expression in Whole Blood or Markers of Methylglyoxal Stress: The CODAM Study
por: Maasen, Kim, et al.
Publicado: (2021)

Increased methylglyoxal formation in plasma and tissues during a glucose tolerance test is derived from exogenous glucose
por: Zhang, Xiaodi, et al.
Publicado: (2023)

Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASH
por: Bruschi, Francesca V., et al.
Publicado: (2020)

Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease
por: Sangineto, Moris, et al.
Publicado: (2020)

Absence of Bsep/Abcb11 attenuates MCD diet‐induced hepatic steatosis but aggravates inflammation in mice
por: Fuchs, Claudia D., et al.
Publicado: (2020)

Liver‐related long‐term outcomes of thiazolidinedione use in persons with type 2 diabetes
por: Yen, Fu‐Shun, et al.
Publicado: (2020)

Mesenchymal iron deposition is associated with adverse long‐term outcome in non‐alcoholic fatty liver disease
por: Eder, Sebastian K., et al.
Publicado: (2020)

Serum aromatic and branched‐chain amino acids associated with NASH demonstrate divergent associations with serum lipids
por: de Mello, Vanessa D., et al.
Publicado: (2020)

Interaction between CHOP and FoxO6 promotes hepatic lipid accumulation
por: Kim, Dae Hyun, et al.
Publicado: (2020)

Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real‐world data analysis
por: Colosimo, Santo, et al.
Publicado: (2021)

Clinical practice gaps and challenges in non‐alcoholic steatohepatitis care: An international physician needs assessment
por: Lazure, Patrice, et al.
Publicado: (2022)

PPAR‐γ‐induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH
por: Gastaldelli, Amalia, et al.
Publicado: (2021)

Inflammatory activity affects the accuracy of liver stiffness measurement by transient elastography but not by two‐dimensional shear wave elastography in non‐alcoholic fatty liver disease
por: Mendoza, Yuly P., et al.
Publicado: (2021)

Relationship between drinking frequency and fatty liver prevalence or incidence in Japanese undergoing health checkup in 2008‐2019
por: Sugiyama, Aya, et al.
Publicado: (2021)

Risk of hepatic and extrahepatic cancer in NAFLD: A population‐based cohort study
por: Björkström, Karl, et al.
Publicado: (2022)

Repeated measurements of non‐invasive fibrosis tests to monitor the progression of non‐alcoholic fatty liver disease: A long‐term follow‐up study
por: Balkhed, Wile, et al.
Publicado: (2022)

Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survival
por: Villeret, François, et al.
Publicado: (2022)

Liver stiffness (Fibroscan®) is a predictor of all‐cause mortality in people with non‐alcoholic fatty liver disease
por: Braude, Michael, et al.
Publicado: (2022)

Kidney and vascular function in adult patients with hereditary fructose intolerance
por: Simons, Nynke, et al.
Publicado: (2020)

Effects of fructose restriction on liver steatosis (FRUITLESS); a double-blind randomized controlled trial
por: Simons, Nynke, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality
por: Brouwers, Martijn C. G. J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7c6ld0o6e7hanv5q9a8semu2ki